COVID-19 : Current and Potential Therapeutic Approaches [post]

Asmaa Khalifa, Mai Ghoneim, Bassma Ali
2020 unpublished
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), a new virus from Corona viruses family, was detected in China in December 2019. The virus was suddenly and vigorously disseminated among individuals allover the world hence the control on the virus was lost and COVID-19 pandemic was announced. Scientists start to screen all the available options to treat this newly evolved virus. Till now there is no validated treatment for SARS-CoV-2 patients and all drugs are under clinical
more » ... gation. This mini-review represents a summarized insight for the pathophysiology and the available SARS-CoV-2 therapy with the clinical trials associated with each drug category including antivirals, monoclonal antibodies, anticoagulants, convalescent plasma therapy, miscellaneous and adjuvant therapies.
doi:10.22541/au.159373181.11051834 fatcat:clewa2c6wbdqjhztxs6dhd5bga